Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 478Neoplasms 329Colorectal Neoplasms 234Carcinoma, Non-Small-Cell Lung 233Lung Neoplasms 203Prostatic Neoplasms 180Carcinoma, Hepatocellular 175Stomach Neoplasms 140Pancreatic Neoplasms 122Leukemia, Myeloid, Acute 112Uterine Cervical Neoplasms 107Rectal Neoplasms 104Multiple Myeloma 91Squamous Cell Carcinoma of Head and Neck 85Recurrence 83Neoplasm Metastasis 79Head and Neck Neoplasms 79Ovarian Neoplasms 73Brain Neoplasms 70Colonic Neoplasms 69Triple Negative Breast Neoplasms 66Esophageal Neoplasms 66Glioblastoma 65Endometrial Neoplasms 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Motor Activity 56Small Cell Lung Carcinoma 54Disease 53Hematologic Neoplasms 51Glioma 47

Interventions

Pluvicto 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × High-Risk Localized Prostate Cancer × Clear all
NCT07550517 2026-04-24

PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Not yet recruiting
60 enrolled
Genitourinary

High-Risk Localized Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡